IL16 and experimental autoimmune encephalomyelitis: Furthermore, Skundric et al. [25] demonstrated effectiveness of anti-IL-16 therapy in reducing CD4+ T-cell infiltration of the central nervous system in experimental autoimmune encephalomyelitis in mice.